BR9910115A - Cetolìdeos da classe dos lactamas de 5 elementos - Google Patents

Cetolìdeos da classe dos lactamas de 5 elementos

Info

Publication number
BR9910115A
BR9910115A BR9910115-7A BR9910115A BR9910115A BR 9910115 A BR9910115 A BR 9910115A BR 9910115 A BR9910115 A BR 9910115A BR 9910115 A BR9910115 A BR 9910115A
Authority
BR
Brazil
Prior art keywords
group
class
ketolides
aza
methyl
Prior art date
Application number
BR9910115-7A
Other languages
English (en)
Inventor
Gorjana Lazarevski
Gabrijela Kobrehel
Zeljko Kelneric
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of BR9910115A publication Critical patent/BR9910115A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Abstract

Patente de Invenção: <B>"CETOLìDEOS DA CLASSE DOS LACTAMAS DE 5 ELEMENTOS"<D>. A presente invenção refere-se a novos cetoazalídeos de 15 elementos da classe de 6-O-metil-8a-aza-8a-homo- e 6-O-metil-9a-aza-9a-homoeritromicina A com a fórmula geral (I): em que: A representa um grupo NH e B, ao mesmo tempo, representa um grupo C=O, ou A representa um grupo C=O e B, ao mesmo tempo, representa um grupo NH, R¹ representa um grupo OH, um grupo L-cladinosila da fórmula (II): ou junto com R² representa cetona, R² representa hidrogênio ou junto com R¹ representa cetona, R³ representa hidrogênio ou um grupo C~ 1~-C~ 4~ alcanoíla, a intermediários e a um processo para sua preparação, a seus sais de adição farmaceuticamente aceitáveis com ácidos inorgânicos ou orgânicos, a um processo para a preparação de composições farmacêuticas, bem como ao uso das composições farmacêuticas no tratamento de infecções bacterianas.
BR9910115-7A 1998-04-06 1999-04-02 Cetolìdeos da classe dos lactamas de 5 elementos BR9910115A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR980189A HRP980189B1 (en) 1998-04-06 1998-04-06 Novel 15-membered lactams ketolides
PCT/HR1999/000004 WO1999051616A1 (en) 1998-04-06 1999-04-02 15-membered lactams ketolides with antibacterial activity

Publications (1)

Publication Number Publication Date
BR9910115A true BR9910115A (pt) 2000-12-26

Family

ID=10946724

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910115-7A BR9910115A (pt) 1998-04-06 1999-04-02 Cetolìdeos da classe dos lactamas de 5 elementos

Country Status (27)

Country Link
US (1) US6110965A (pt)
EP (1) EP1070077B1 (pt)
JP (1) JP2002510701A (pt)
KR (1) KR100600463B1 (pt)
CN (1) CN1141312C (pt)
AR (1) AR019261A1 (pt)
AT (1) ATE241638T1 (pt)
AU (1) AU3046499A (pt)
BG (1) BG64600B1 (pt)
BR (1) BR9910115A (pt)
CA (1) CA2327775C (pt)
DE (1) DE69908338T2 (pt)
DK (1) DK1070077T3 (pt)
EE (1) EE04283B1 (pt)
ES (1) ES2200512T3 (pt)
HK (1) HK1036457A1 (pt)
HR (1) HRP980189B1 (pt)
HU (1) HUP0101817A3 (pt)
IL (2) IL138837A0 (pt)
NO (1) NO317982B1 (pt)
PL (1) PL193742B1 (pt)
PT (1) PT1070077E (pt)
RU (1) RU2211222C2 (pt)
SI (1) SI1070077T1 (pt)
SK (1) SK284169B6 (pt)
UA (1) UA70941C2 (pt)
WO (1) WO1999051616A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
OA12845A (en) * 2001-08-21 2006-09-15 Pfizer Prod Inc Single dose azithromycin for treating respiratory infections.
AU2003211113B2 (en) 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
US20050171342A1 (en) 2002-02-15 2005-08-04 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483579A4 (en) 2002-02-15 2006-07-12 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
CA2489402A1 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
EP1551865B1 (en) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
RS51479B (en) 2005-01-13 2011-04-30 Glaxo Group Limited MACROLIDES WITH ANTI-INFLAMMATORY ACTION
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
WO2007129646A1 (ja) * 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体
WO2009007988A1 (en) * 2007-07-11 2009-01-15 Alembic Limited Process for the preparation of 6-o-methylerythromycin a 9-oxime
EA201101139A1 (ru) 2009-01-30 2012-03-30 Глэксо Груп Лимитед Противовоспалительный макролид
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
RU2601550C2 (ru) * 2010-12-09 2016-11-10 Вокхардт Лимитед Кетолидные соединения
SG11202105227QA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C10-alkylene substituted 13-membered macrolides and uses thereof
EP4051289A4 (en) * 2019-10-29 2024-03-27 Hikal Ltd ESSENTIALLY PURE CLARITHROMYCIN 9-OXIME AND ITS PRODUCTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
US5202434A (en) * 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
EP0699207B1 (en) * 1993-05-19 1997-06-25 Pfizer Inc. Intermediate for azithromycin

Also Published As

Publication number Publication date
EE04283B1 (et) 2004-04-15
BG104913A (en) 2001-08-31
SK284169B6 (sk) 2004-10-05
AU3046499A (en) 1999-10-25
IL138837A (en) 2006-10-05
NO20005015L (no) 2000-12-04
AR019261A1 (es) 2002-02-13
DE69908338T2 (de) 2004-04-08
CN1301268A (zh) 2001-06-27
CA2327775C (en) 2007-08-07
SK15022000A3 (sk) 2001-03-12
IL138837A0 (en) 2001-10-31
WO1999051616A1 (en) 1999-10-14
JP2002510701A (ja) 2002-04-09
CN1141312C (zh) 2004-03-10
RU2211222C2 (ru) 2003-08-27
NO20005015D0 (no) 2000-10-05
KR100600463B1 (ko) 2006-07-13
EE200000587A (et) 2002-04-15
SI1070077T1 (en) 2004-02-29
DK1070077T3 (da) 2003-09-22
HRP980189A2 (en) 2000-12-31
EP1070077A1 (en) 2001-01-24
HUP0101817A3 (en) 2003-07-28
NO317982B1 (no) 2005-01-17
KR20010034754A (ko) 2001-04-25
HUP0101817A2 (hu) 2001-11-28
CA2327775A1 (en) 1999-10-14
UA70941C2 (uk) 2004-11-15
DE69908338D1 (de) 2003-07-03
PT1070077E (pt) 2003-10-31
PL343441A1 (en) 2001-08-13
ES2200512T3 (es) 2004-03-01
BG64600B1 (bg) 2005-08-31
ATE241638T1 (de) 2003-06-15
HK1036457A1 (en) 2002-01-04
US6110965A (en) 2000-08-29
EP1070077B1 (en) 2003-05-28
PL193742B1 (pl) 2007-03-30
HRP980189B1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
BR9910115A (pt) Cetolìdeos da classe dos lactamas de 5 elementos
BR9810097A (pt) Derivados de macrolìdeos c-4-substituìdos
BR9814601A (pt) &#34;macrólidos&#34;
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
BR9810021A (pt) Derivados 9-oxima-eritromicina
BR9714787A (pt) Compostos de 4- fenilpiperidina e processo para sua preparação
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
BRPI9914741A (pt) n-(2-aril-proprionil)-sulfonamidas, usos e composições farmacêuticas contendo as mesmas.
BRPI9915480B8 (pt) azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos.
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
BR9914998A (pt) Antibióticos macrólidos
BR9714032A (pt) Uso de derivados ácido 7-(2-oxa-5,8-diazabiciclo[4.3.0]non-8-il]-quinolonacarb oxìlico e -naftilridonacarboxìlico para a terapia de infecções de heliocobacter pylori e as desordens gastroduodenais associadas com as mesmas
BR9812148A (pt) Derivados de eritromicina 6,9-ligados em ponte
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
BR9908470A (pt) Composto, composição farmacêutica, e, processo para tratar condições mediadas pela inegrina avb3 em um mamìfero em necessidade de tal tratamento
BR0212069A (pt) Agentes antidiabéticos orais
BR9812577A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas
BR9905089A (pt) Derivados macrolìdeos
BR9815296A (pt) Derivados de ácido carboxìlico 3-pirrolidina e ouso dos mesmos como antagonistas endotelina
HUP0102903A2 (hu) Nokatiacin antibiotikumok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
PT870761E (pt) Derivados de tiocolchicina com actividades anti-inflamatoria e relaxante muscular
BR9510429A (pt) Composto composição farmacêutica processo para produzir o composto e uso do composto
BR9805437A (pt) Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 10 (VIII) DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.